6505--Topiramate Tablets (VA-25-00047941)

The Department of Veterans Affairs National Acquisition Center is seeking pharmaceutical suppliers for Topiramate Tablets across multiple strengths (25mg, 50mg, 100mg, and 200mg). This solicitation (36E79725R0031) is an unrestricted contract opportunity targeting suppliers capable of providing tablets for VA, Department of Defense, Indian Health Service, and Bureau of Prisons through Pharmaceutical Prime Vendor programs. Key contract requirements include FDA-approved manufacturing facilities with current Good Manufacturing Practices (cGMP), unique NDC numbers for each product, and specific safety-cap bottle packaging. The procurement is structured as a firm fixed-price requirements contract with a base year and four one-year option periods, with proposals due by May 19, 2025, at 2:30 PM Central Time. While specific evaluation criteria are not explicitly detailed, offerors must submit comprehensive pricing for base and option years, including a mandatory 0.5% Cost Recovery Fee.

The solicitation is technically unrestricted but includes small business representations, with potential suppliers required to be registered in the System for Award Management (SAM). Estimated annual usage varies significantly by agency, with quantities ranging from 11,661 to 78,190 bottles depending on tablet strength and package size. The contract will result in a single aggregate award covering all line items, with distribution managed through VA and DoD Pharmaceutical Prime Vendor networks. Suppliers must price their offerings to two decimal places and meet stringent pharmaceutical manufacturing standards. Performance will likely be distributed across multiple federal healthcare facilities, with the VA National Acquisition Center in Hines, Illinois serving as the primary contracting authority. The total contract duration spans five years, providing substantial opportunity for pharmaceutical manufacturers to establish a consistent supply relationship with federal healthcare agencies.